Post-natal corticosteroids are associated with reduced expiratory flows in children born very preterm

Lucia J Smith1, Peter P van Asperen, Karen O McKay

  • 1Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.

Insights

Corticosteroids given to premature infants did not impact school-age lung function, but postnatal steroids were linked to reduced airflow. Further research is needed on postnatal corticosteroid effects on lung development.

Area of Science:

  • Pediatric Pulmonology
  • Neonatal Medicine
  • Respiratory Medicine

Background:

  • Infants born very prematurely often receive corticosteroids to reduce the risk of bronchopulmonary dysplasia (BPD).
  • The long-term effects of these treatments on school-age lung function remain unclear.
  • Understanding these impacts is crucial for optimizing respiratory care in preterm infants.

Purpose of the Study:

  • To investigate the long-term impact of corticosteroid treatment on school-age lung function in very preterm infants.
  • To determine if a BPD diagnosis or antenatal/postnatal corticosteroid exposure affects lung function at approximately 10 years of age.

Main Methods:

  • A cross-sectional study included 105 children born at a mean gestation of 27 weeks.
  • Lung function was assessed at a mean age of 10 years using spirometry.
  • Corticosteroid exposure (antenatal and postnatal) was documented from medical records.

Main Results:

  • Children with BPD showed no significant difference in spirometry compared to those without BPD.
  • Antenatal corticosteroid treatment alone did not adversely affect lung airflow.
  • Children who received postnatal corticosteroids exhibited significantly lower expiratory airflow (FEV1 and FEF25%-75%) compared to those who did not.

Conclusions:

  • A BPD diagnosis did not predict reduced lung function in middle childhood.
  • Postnatal corticosteroid exposure in preterm infants was associated with reduced expiratory airflow at school age.
  • While postnatal corticosteroids may indicate lung disease severity, their direct impact on lung development warrants further investigation.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...